The LPS receptor, CD14, in experimental autoimmune encephalomyelitis and multiple sclerosis

Area of Science:

• Immunology
• Neuroscience
• Pathophysiology

Background:

• Innate immune receptors are vital for host defense against pathogens.
• Emerging evidence suggests interplay between innate and adaptive immunity.
• The lipopolysaccharide receptor (CD14) is a key component of the innate immune system.

Purpose of the Study:

• To investigate the role of the lipopolysaccharide receptor (CD14) in the pathophysiology of experimental autoimmune encephalomyelitis (EAE).
• To explore the potential involvement of CD14 in multiple sclerosis (MS).

Main Methods:

• Utilized a mouse model of experimental autoimmune encephalomyelitis (EAE).
• Assessed clinical disease severity and central nervous system immune cell infiltration in CD14-deficient mice.
• Examined CD14 immunoreactivity in brain tissues from multiple sclerosis patients and controls.

Main Results:

• CD14 deficiency exacerbated clinical symptoms in active EAE.
• CD14-deficient mice showed increased infiltration of monocytes and neutrophils into the brain and spinal cord.
• Elevated CD14 immunoreactivity was observed in brain tissues of multiple sclerosis patients.

Conclusions:

• The lipopolysaccharide receptor (CD14) plays a significant role in the pathogenesis of EAE.
• CD14 may be a relevant factor in the pathophysiology of multiple sclerosis.
• Targeting CD14 could be a potential therapeutic strategy for MS.